Pravastatin

Pravastatin is a statin, a medicine taken by mouth to lower LDL cholesterol. The FDA label says it is indicated to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia.

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 42463; UNII 3M8608UQ61. The label names the substance as pravastatin sodium, so UNII 3M8608UQ61 is the UNII of the salt form and is a broad match. MeSH descriptor D017035 is Pravastatin. Class: HMG-CoA Reductase Inhibitor (FDA established pharmacologic class, RxClass). The label read is the Teva Pharmaceuticals USA, Inc. label for pravastatin sodium tablets (pravastatin sodium), application ANDA076056, effective 2024-01-01 in openFDA. This page records the label indication and the class only: no trial result and no dose is given.

Trials at a glance

The figures count the 4 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
4
Phase 3 or 4
4
Recruiting
0
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseCompletedTerminatedUnknown statusAll statuses
Phase 31102
Phase 41012
All phases2114

Conditions these trials study

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

About this drug

Level
Substance
Mechanism
Not reported

Classification codes

  • UNII 3M8608UQ61

Claims and evidence

Context People for whom the US label of pravastatin lists an indication: adults with primary hyperlipidemia

Recipient
Adult
Population
Patients described in the indications section of the label, the passage read here being the adult LDL-cholesterol (LDL cholesterol) indication.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Adults, as the passage read states
Follow-up
Not applicable (label statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Adults with primary hyperlipidemia
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of pravastatin sodium tablets (pravastatin sodium), in the Teva Pharmaceuticals USA, Inc. version dated 2024-01-01 in openFDA, lists the medicine to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia.

    Applies to Adult People for whom the US label of pravastatin lists an indication: adults with primary hyperlipidemia

    Certainty method
    Not assessed
    Limitations
    This claim records one thing the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label lists other indications that were not recorded; contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-07
    Next evidence check due
    Not scheduled
    Sources and citations (2)
    1. Supports openFDA drug label record for pravastatin sodium tablets (pravastatin sodium), Teva Pharmaceuticals USA, Inc. label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 99e0e848-f8f3-4b42-b880-8fbc42633948 (manufacturer Teva Pharmaceuticals USA, Inc., application ANDA076056), returned on 2026-11-07. The label text is dated 2024-01-01 (effective_time). Other openFDA records of pravastatin labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      The label sentence that gives the LDL-cholesterol indication.
      Retrieved
      Source effective date
      2024-01-01
      Source state
      Current
      Version fingerprint
      ed95365689d1e69f921584e7adab83c556914d79322fb72940fb9d38affe023f
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Background openFDA drug label record for pravastatin sodium tablets (pravastatin sodium), Teva Pharmaceuticals USA, Inc. label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 99e0e848-f8f3-4b42-b880-8fbc42633948 (manufacturer Teva Pharmaceuticals USA, Inc., application ANDA076056), returned on 2026-11-07. The label text is dated 2024-01-01 (effective_time). Other openFDA records of pravastatin labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20240101.
      Retrieved
      Source effective date
      2024-01-01
      Source state
      Current
      Version fingerprint
      ed95365689d1e69f921584e7adab83c556914d79322fb72940fb9d38affe023f
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 4

Record details

Record id
cardio:pravastatin
Content hash
0e00b08018a41e5fbf4133cc6170059151f023cad6aeba514448e871891ca632